FDA Drug Recalls

Recalls / Class III

Class IIID-0647-2017

Product

Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05

Affected lot / code info
Lot #: 6111141, Exp. 07/17; 6111222, Exp. 08/17; 6112346, Exp. 01/18; 6112725, Exp. 03/18

Why it was recalled

Subpotent Drug

Recalling firm

Firm
Fresenius Kabi USA, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
3 Corporate Dr, N/A, Lake Zurich, Illinois 60047-8930

Distribution

Quantity
118,224 vials
Distribution pattern
Nationwide within the US

Timeline

Recall initiated
2017-03-16
FDA classified
2017-04-05
Posted by FDA
2017-04-12
Terminated
2018-08-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0647-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.